.png)
Live Cell Imaging Market By Product, Application and Technology - Global Industry Analysis and Forecast to 2027
Published On : August 2018 Pages : 190 Category: Biotechnology Report Code : HC081168
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
Live cell imaging is the investigation of cells continuously utilizing the pictures acquired from screening frameworks and magnifying lens. The innovation has adjusted the approach of researchers to think about proteins, atomic collaborations and inward structures of cells, cell forms and comprehend organic capacities. It empowers them to watch cells to get an inside and out investigation as opposed to concentrate the pictures of settled cells. Data with more accuracy can be acquired utilizing live cell imaging, which assumes a critical part in understanding cell flow in explore fields, for example, immunology, hereditary qualities, neurology, microbiology and others. Innovative headways in live cell imaging will satisfy the requests of scholarly establishments, government associations, pharmaceutical organizations and symptomatic labs.
Drivers & Restrains Outlook and Trend Analysis
The key components driving the world live cell imaging market are appropriation of high-content screening procedures, colossal government financing for cell based research, and rising frequencies of growth around the world. In any case, the shortage of gifted experts and staggering expense of high-content screening frameworks is a portion of the main considerations controlling the development of the market. The appropriation of high-content screening frameworks for essential screening and uses of live cell imaging in customized solutions presents development open doors for the market players.
Regional Outlook and Trend Analysis
North America overwhelmed by piece of the overall industry in 2017 intently took after by Europe. Liberal speculations and subsidizing accessible for look into in this field is the key driver in this district. Europe additionally held a noteworthy offer because of early appropriation of innovation. The developing maturing populace requests for concentrated research in perpetual sicknesses, for example, malignancy, neurodegeneration, and cardiovascular ailments. This has favoured immature microorganism explore and propelled microscopy.
Competitive Insights
The leading players in the market are Leica Microsystems, Becton, Dickinson and Company, Olympus Corporation, Carl Zeiss Meditec AG, Thermo Fisher Scientific, Inc. and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Live Cell Imaging Market is segmented as follows-
By Product:
- Consumable
- Software
- Equipment
By Technology:
- Fluorescence resonance energy transfer (FRET)
- Time lapse Microscopy
- Fluorescence recovery after photobleaching (FRAP)
- High content screening (HCS)
- Other Technologies
By Application:
- Developmental Biology
- Cell Biology
- Stem Cell & Drug Discovery
- Other Applications
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Live Cell Imaging Market, By Product, Estimates and Forecast, 2017-2027($Billion)
o Consumable
o Equipment
o Software
· Live Cell Imaging Market, By Application, Estimates and Forecast, 2017-2027($Billion)
o Developmental Biology
o Cell Biology
o Stem Cell & Drug Discovery
o Other Applications
· Live Cell Imaging Market, By Technology, Estimates and Forecast, 2017-2027($Billion)
o Fluorescence recovery after photobleaching (FRAP)
o Time lapse Microscopy
o Fluorescence resonance energy transfer (FRET)
o High content screening (HCS)
o Other Technologies
· Live Cell Imaging Market, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Live Cell Imaging Market, By Country
o U.S. Live Cell Imaging Market
o Canada Live Cell Imaging Market
o Mexico Live Cell Imaging Market
o Europe
§ Europe Live Cell Imaging Market, By Country
o Germany Live Cell Imaging Market
o UK Live Cell Imaging Market
o France Live Cell Imaging Market
o Russia Live Cell Imaging Market
o Italy Live Cell Imaging Market
o Rest of Europe Live Cell Imaging Market
o Asia-Pacific
§ Asia-Pacific Live Cell Imaging Market, By Country
o China Live Cell Imaging Market
o Japan Live Cell Imaging Market
o South Korea Live Cell Imaging Market
o India Live Cell Imaging Market
o Southeast Asia Live Cell Imaging Market
o Rest of Asia-Pacific Live Cell Imaging Market
o South America
§ South America Live Cell Imaging Market
o Brazil Live Cell Imaging Market
o Argentina Live Cell Imaging Market
o Columbia Live Cell Imaging Market
o Rest of South America Live Cell Imaging Market
o Middle East and Africa
§ Middle East and Africa Live Cell Imaging Market
o Saudi Arabia Live Cell Imaging Market
o UAE Live Cell Imaging Market
o Egypt Live Cell Imaging Market
o Nigeria Live Cell Imaging Market
o South Africa Live Cell Imaging Market
o Rest of MEA Live Cell Imaging Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Live Cell Imaging Market, By Product
5.1. Introduction
5.2. Global Live Cell Imaging Revenue and Market Share by Product (2017-2027)
5.2.1. Global Live Cell Imaging Revenue and Revenue Share by Product (2017-2027)
5.3. Consumable
5.3.1. Global Consumable Revenue and Growth Rate (2017-2027)
5.4. Equipment
5.4.1. Global Equipment Revenue and Growth Rate (2017-2027)
5.5. Software
5.5.1. Global Software Revenue and Growth Rate (2017-2027)
6. Live Cell Imaging Market, By Application
6.1. Introduction
6.2. Global Live Cell Imaging Revenue and Market Share by Application (2017-2027)
6.2.1. Global Live Cell Imaging Revenue and Revenue Share by Application (2017-2027)
6.3. Developmental Biology
6.3.1. Global Developmental Biology Revenue and Growth Rate (2017-2027)
6.4. Cell Biology
6.4.1. Global Cell Biology Revenue and Growth Rate (2017-2027)
6.5. Stem Cell & Drug Discovery
6.5.1. Global Stem Cell & Drug Discovery Revenue and Growth Rate (2017-2027)
6.6. Other Applications
6.6.1. Global Other Applications Revenue and Growth Rate (2017-2027)
7. Live Cell Imaging Market, By Technology
7.1. Introduction
7.2. Global Live Cell Imaging Revenue and Market Share by Technology (2017-2027)
7.2.1. Global Live Cell Imaging Revenue and Revenue Share by Technology (2017-2027)
7.3. Fluorescence recovery after photobleaching (FRAP)
7.3.1. Global Fluorescence recovery after photobleaching (FRAP) Revenue and Growth Rate (2017-2027)
7.4. Time lapse Microscopy
7.4.1. Global Time lapse Microscopy Revenue and Growth Rate (2017-2027)
7.5. Fluorescence resonance energy transfer (FRET)
7.5.1. Global Fluorescence resonance energy transfer (FRET) Revenue and Growth Rate (2017-2027)
7.6. High content screening (HCS)
7.6.1. Global High content screening (HCS) Revenue and Growth Rate (2017-2027)
7.7. Other Technologies
7.7.1. Global Other Technologies Revenue and Growth Rate (2017-2027)
8. Live Cell Imaging Market, By Region
8.1. Introduction
8.2. Global Live Cell Imaging Revenue and Market Share by Regions
8.2.1. Global Live Cell Imaging Revenue by Regions (2017-2027)
8.3. North America Live Cell Imaging by Countries
8.3.1. North America Live Cell Imaging Revenue and Growth Rate (2017-2027)
8.3.2. North America Live Cell Imaging Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Live Cell Imaging by Countries
8.4.1. Europe Live Cell Imaging Revenue and Growth Rate (2017-2027)
8.4.2. Europe Live Cell Imaging Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Live Cell Imaging by Countries
8.5.1. Asia-Pacific Live Cell Imaging Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Live Cell Imaging Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Live Cell Imaging by Countries
8.6.1. South America Live Cell Imaging Revenue and Growth Rate (2017-2027)
8.6.2. South America Live Cell Imaging Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Live Cell Imaging by Countries
8.7.1. Middle East and Africa Live Cell Imaging Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Live Cell Imaging Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Leica Microsystems
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Carl Zeiss
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Nikon Corporation
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Becton, Dickinson and Company
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Olympus Corporation
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. GE Healthcare
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Thermo Fisher Scientific, Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Sigma-Aldrich Corporation
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. PerkinElmer, Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Molecular Devices, LCC
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Live Cell Imaging Market Forecast (2017-2027)
10.1. Global Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Live Cell Imaging Market Forecast by Regions (2017-2027)
10.2.1. North America Live Cell Imaging Market Forecast (2017-2027)
10.2.1.1. United States Live Cell Imaging Market Forecast (2017-2027)
10.2.1.2. Canada Live Cell Imaging Market Forecast (2017-2027)
10.2.1.3. Mexico Live Cell Imaging Market Forecast (2017-2027)
10.2.2. Europe Live Cell Imaging Market Forecast (2017-2027)
10.2.2.1. Germany Live Cell Imaging Market Forecast (2017-2027)
10.2.2.2. France Live Cell Imaging Market Forecast (2017-2027)
10.2.2.3. UK Live Cell Imaging Market Forecast (2017-2027)
10.2.2.4. Russia Live Cell Imaging Market Forecast (2017-2027)
10.2.2.5. Italy Live Cell Imaging Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Live Cell Imaging Market Forecast (2017-2027)
10.2.3. Asia-Pacific Live Cell Imaging Market Forecast (2017-2027)
10.2.3.1. China Live Cell Imaging Market Forecast (2017-2027)
10.2.3.2. Japan Live Cell Imaging Market Forecast (2017-2027)
10.2.3.3. Korea Live Cell Imaging Market Forecast (2017-2027)
10.2.3.4. India Live Cell Imaging Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Live Cell Imaging Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Live Cell Imaging Market Forecast (2017-2027)
10.2.4. South America Live Cell Imaging Market Forecast (2017-2027)
10.2.4.1. Brazil Live Cell Imaging Market Forecast (2017-2027)
10.2.4.2. Argentina Live Cell Imaging Market Forecast (2017-2027)
10.2.4.3. Columbia Live Cell Imaging Market Forecast (2017-2027)
10.2.4.4. Rest of South America Live Cell Imaging Market Forecast (2017-2027)
10.2.5. Middle East and Africa Live Cell Imaging Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Live Cell Imaging Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Live Cell Imaging Market Forecast (2017-2027)
10.2.5.3. Egypt Live Cell Imaging Market Forecast (2017-2027)
10.2.5.4. Nigeria Live Cell Imaging Market Forecast (2017-2027)
10.2.5.5. South Africa Live Cell Imaging Market Forecast (2017-2027)
10.2.5.6. Turkey Live Cell Imaging Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Live Cell Imaging Market Forecast (2017-2027)
10.3. Live Cell Imaging Market Forecast by Product (2017-2027)
10.3.1. Live Cell Imaging Forecast by Product (2017-2027)
10.3.2. Live Cell Imaging Market Share Forecast by Product (2017-2027)
10.4. Live Cell Imaging Market Forecast by Application (2017-2027)
10.4.1. Live Cell Imaging Forecast by Application (2017-2027)
10.4.2. Live Cell Imaging Market Share Forecast by Application (2017-2027)
10.5. Live Cell Imaging Market Forecast by Technology (2017-2027)
10.5.1. Live Cell Imaging Forecast by Technology (2017-2027)
10.5.2. Live Cell Imaging Market Share Forecast by Technology (2017-2027)
List of Tables
Figure United States Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Live Cell Imaging Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Live Cell Imaging Revenue and Revenue Share by Product (2017-2018)
Figure Global Consumable Revenue and Growth Rate (2017-2018)
Figure Global Equipment Revenue and Growth Rate (2017-2018)
Figure Global Software Revenue and Growth Rate (2017-2018)
Table Global Live Cell Imaging Revenue and Revenue Share by Application (2017-2018)
Figure Global Developmental Biology Revenue and Growth Rate (2017-2018)
Figure Global Cell Biology Revenue and Growth Rate (2017-2018)
Figure Global Stem Cell & Drug Discovery Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global Live Cell Imaging Revenue and Revenue Share by Technology (2017-2018)
Figure Global Fluorescence recovery after photobleaching (FRAP) Revenue and Growth Rate (2017-2018)
Figure Global Time lapse Microscopy Revenue and Growth Rate (2017-2018)
Figure Global Fluorescence resonance energy transfer (FRET) Revenue and Growth Rate (2017-2018)
Figure Global High content screening (HCS) Revenue and Growth Rate (2017-2018)
Figure Global Other Technologies Revenue and Growth Rate (2017-2018)
Table Global Live Cell Imaging Revenue by Regions (2017-2018)
Figure North America Live Cell Imaging Growth Rate (2017-2018)
Figure North America Live Cell Imaging Revenue and Growth Rate (2017-2018)
Figure North America Live Cell Imaging by Countries (2017-2018)
Figure North America Live Cell Imaging Revenue (Million USD) by Countries (2017-2018)
Figure United States Live Cell Imaging Growth Rate (2017-2018)
Figure United States Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Live Cell Imaging Growth Rate (2017-2018)
Figure Canada Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Live Cell Imaging Growth Rate (2017-2018)
Figure Mexico Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Live Cell Imaging Growth Rate (2017-2018)
Figure Europe Live Cell Imaging Revenue and Growth Rate (2017-2018)
Figure Europe Live Cell Imaging by Countries (2017-2018)
Figure Europe Live Cell Imaging Revenue (Million USD) by Countries (2017-2018)
Figure Germany Live Cell Imaging Growth Rate (2017-2018)
Figure Germany Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Live Cell Imaging Growth Rate (2017-2018)
Figure France Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Live Cell Imaging Growth Rate (2017-2018)
Figure UK Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Live Cell Imaging Growth Rate (2017-2018)
Figure Russia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Live Cell Imaging Growth Rate (2017-2018)
Figure Italy Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Live Cell Imaging Growth Rate (2017-2018)
Figure Rest of Europe Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Live Cell Imaging Growth Rate (2017-2018)
Figure Asia-Pacific Live Cell Imaging Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Live Cell Imaging by Countries (2017-2018)
Figure Asia-Pacific Live Cell Imaging Revenue (Million USD) by Countries (2017-2018)
Figure China Live Cell Imaging Growth Rate (2017-2018)
Figure China Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Live Cell Imaging Growth Rate (2017-2018)
Figure Japan Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Live Cell Imaging Growth Rate (2017-2018)
Figure Korea Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Live Cell Imaging Growth Rate (2017-2018)
Figure India Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Live Cell Imaging Growth Rate (2017-2018)
Figure Southeast Asia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Live Cell Imaging Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Live Cell Imaging Growth Rate (2017-2018)
Figure South America Live Cell Imaging Revenue and Growth Rate (2017-2018)
Figure South America Live Cell Imaging by Countries (2017-2018)
Figure South America Live Cell Imaging Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Live Cell Imaging Growth Rate (2017-2018)
Figure Brazil Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Live Cell Imaging Growth Rate (2017-2018)
Figure Argentina Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Live Cell Imaging Growth Rate (2017-2018)
Figure Columbia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Live Cell Imaging Growth Rate (2017-2018)
Figure Rest of South America Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Live Cell Imaging Growth Rate (2017-2018)
Figure Middle East and Africa Live Cell Imaging Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Live Cell Imaging by Countries (2017-2018)
Figure Middle East and Africa Live Cell Imaging Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Live Cell Imaging Growth Rate (2017-2018)
Figure Saudi Arabia Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Live Cell Imaging Growth Rate (2017-2018)
Figure United Arab Emirates Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Live Cell Imaging Growth Rate (2017-2018)
Figure Egypt Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Live Cell Imaging Growth Rate (2017-2018)
Figure Nigeria Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Live Cell Imaging Growth Rate (2017-2018)
Figure South Africa Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Live Cell Imaging Growth Rate (2017-2018)
Figure Turkey Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Live Cell Imaging Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Live Cell Imaging Revenue (Millions USD) and Growth Rate (2017-2018)
Table Leica Microsystems Live Cell Imaging Financial Overview
Table Carl Zeiss Live Cell Imaging Financial Overview
Table Nikon Corporation Live Cell Imaging Financial Overview
Table Becton, Dickinson and Company Live Cell Imaging Financial Overview
Table Olympus Corporation Live Cell Imaging Financial Overview
Table GE Healthcare Live Cell Imaging Financial Overview
Table Thermo Fisher Scientific, Inc. Live Cell Imaging Financial Overview
Table Sigma-Aldrich Corporation Live Cell Imaging Financial Overview
Table PerkinElmer, Inc. Live Cell Imaging Financial Overview
Table Molecular Devices, LCC Live Cell Imaging Financial Overview
Figure Global Live Cell Imaging Revenue (Millions USD) and Growth Rate (2018-2025)
Table Live Cell Imaging Market Forecast by Regions (2018-2025)
Figure North America Live Cell Imaging Market Forecast (2018-2025)
Figure United States Live Cell Imaging Market Forecast (2018-2025)
Figure Canada Live Cell Imaging Market Forecast (2018-2025)
Figure Mexico Live Cell Imaging Market Forecast (2018-2025)
Figure Europe Live Cell Imaging Market Forecast (2018-2025)
Figure Germany Live Cell Imaging Market Forecast (2018-2025)
Figure France Live Cell Imaging Market Forecast (2018-2025)
Figure UK Live Cell Imaging Market Forecast (2018-2025)
Figure Russia Live Cell Imaging Market Forecast (2018-2025)
Figure Italy Live Cell Imaging Market Forecast (2018-2025)
Figure Rest of Europe Live Cell Imaging Market Forecast (2018-2025)
Figure Asia-Pacific Live Cell Imaging Market Forecast (2018-2025)
Figure China Live Cell Imaging Market Forecast (2018-2025)
Figure Japan Live Cell Imaging Market Forecast (2018-2025)
Figure Korea Live Cell Imaging Market Forecast (2018-2025)
Figure India Live Cell Imaging Market Forecast (2018-2025)
Figure Southeast Asia Live Cell Imaging Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Live Cell Imaging Market Forecast (2018-2025)
Figure South America Live Cell Imaging Market Forecast (2018-2025)
Figure Brazil Live Cell Imaging Market Forecast (2018-2025)
Figure Argentina Live Cell Imaging Market Forecast (2018-2025)
Figure Columbia Live Cell Imaging Market Forecast (2018-2025)
Figure Rest of South America Live Cell Imaging Market Forecast (2018-2025)
Figure Middle East and Africa Live Cell Imaging Market Forecast (2018-2025)
Figure Saudi Arabia Live Cell Imaging Market Forecast (2018-2025)
Figure United Arab Emirates Live Cell Imaging Market Forecast (2018-2025)
Figure Egypt Live Cell Imaging Market Forecast (2018-2025)
Figure Nigeria Live Cell Imaging Market Forecast (2018-2025)
Figure South Africa Live Cell Imaging Market Forecast (2018-2025)
Figure Turkey Live Cell Imaging Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Live Cell Imaging Market Forecast (2018-2025)
Figure Global Live Cell Imaging Forecast by Product (2018-2025)
Figure Global Live Cell Imaging Market Share Forecast by Product (2018-2025)
Figure Global Live Cell Imaging Forecast by Product (2018-2025)
Figure Global Live Cell Imaging Forecast by Application (2018-2025)
Figure Global Live Cell Imaging Market Share Forecast by Application (2018-2025)
Figure Global Live Cell Imaging Forecast by Application (2018-2025)
Figure Global Live Cell Imaging Forecast by Technology (2018-2025)
Figure Global Live Cell Imaging Market Share Forecast by Technology (2018-2025)
Figure Global Live Cell Imaging Forecast by Technology (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|